LC-1800 Auto Chemininescence Immunoassay Analyzer

LC-1800-Auto-Chemininescence-Immunoassay-Analyzer

Working principle:

Based on various antigen-antibody immunoreaction modes, the full automatic chemiluminescence immunoassay analyzer takes paramagnetic particles as the carrier, and makes useof the direct chemiluminescence method of acridinium ester. It produces unstable intermediates in excited state under the action of free energy released in chemical reaction. When the intermediates get back to the ground state from the excited state, the photons with the same energy level are released.

At this point, it measures such photons and thus conducts the quantitative analysis. Theluminescent intensity of the reaction is proportional to the concentration in the sample within the detection range.

Specifications:

General Information
Throughput120 tests / hour
Result15 mins for the first result
Working principleDirect chemiluminescence method of acridinium ester
Repeatability within batchCV ≤ 5%
Dimensions433mm×680m×640mm (L× W × H)
Net Weight62kg
Samlple Supply System
Sample position30
Sample volume10μL-200μL
Sample loadingSample rack
Sample typeSerum / Plasma / Whole blood / Urine
Reagent System
Reagent position10
Reagent volume10μL-200μL
Reagent loadingReagent carousel
Reagent temperature24h refrigeration, reagent disk temperature: 2 °C – 8 °C
Reaction System
Capacity52 reaction vessels
Reaction volume≤400μL/Test
Incubation temperature37.0±0.3°C
Mixing systemNon-contact eccentric vortex mixer
Operating Conditions
Power supplyAC220V, 50HZ
Power consumption630VA
Temperature10-30℃
Ambient humidity≦70%

Test Items:

InflammationPCT, IL-6, CRP
Tumor MarkersFerritin, CYFRA21-1, SCC, NSE, HE4, TNFα, CEA, CA125, CA15-3, CA242, CA50, CA72-4, CA19-9
Gastric FunctionPGⅠ, PGⅡ
CardioNT-proBNP, hs-cTnI, CK-MB, H-FABP, MYO, HCY, Lp-pLA2, S100-β, BNP
ThyroidTT3, TT4, FT3, FT4, TSH, TGAB, Anti-TPO
Bone Metabolism25-OH-VD, BGP
Sex Hormoneβ-HCG, PRL, LH, FSH, E2, AMH, Prog, T
HypertensionALD, Renin, Cort
ThrombusFDP, D-Dimer
Alzheimer’s diseaseAβ1-42, P-tau-181, AD7c-NTP

About The Author